About this trial
The study will assess the efficacy of a standardized postoperative patient-centered intervention designed to educate patients on the opioid epidemic, the judicious use of opioids, and the proper disposal of opioids. This trial is a single-institution, randomized controlled trial comparing total post-discharge opioid use in breast reconstruction patients who view an educational video on proper opioid use to patients who do not receive intentional education (the current standard of care).
This will be the first project to inform opioid prescribing guidelines for breast reconstruction patients based on actual opioid use data and will describe a patient-centered intervention that is easily incorporated into current postoperative workflows. Broadly, the results of the study aim to set the foundation to incorporate cost-effective educational interventions across multiple surgical specialties that require postoperative opioid prescription.
Eligibility criteria
Qualifiers
Female patients 18 years of age or older
Patients undergoing abdominally based autologous free flap breast reconstruction after mastectomy for breast cancer or cancer prophylaxis
Disqualifiers
Patients undergoing reoperations such as autologous breast reconstruction as a revision procedure following failed implant-based reconstruction
Patients undergoing multiple procedures such as mastectomy and immediate reconstruction
Patients with documented chronic opioid use prior to procedure, chronic pain condition
Trial design
Treatments tested in this trial
- Opioid Educational Video